Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1355

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 5
Chunk 1355
---
reviewing
                                            and discussing with management and the independent auditor the annual audited financial statements,
                                            and recommending to the board whether the audited financial statements should be included
                                            in our annual disclosure report;

●discussing
                                            with management and the independent auditor significant financial reporting issues and judgments
                                            made in connection with the preparation of our financial statements;

●discussing
                                            with management major risk assessment and risk management policies;

●monitoring
                                            the independence of the independent auditor;

●verifying
                                            the rotation of the lead (or coordinating) audit partner having primary responsibility for
                                            the audit and the audit partner responsible for reviewing the audit as required by law;

●reviewing
                                            and approving all related-party transactions;

●inquiring
                                            and discussing with management our compliance with applicable laws and regulations;

●pre-approving
                                            all audit services and permitted non-audit services to be performed by our independent auditor,
                                            including the fees and terms of the services to be performed;

●appointing
                                            or replacing the independent auditor;

●determining
                                            the compensation and oversight of the work of the independent auditor (including resolution
                                            of disagreements between management and the independent auditor regarding financial reporting)
                                            for the purpose of preparing or issuing an audit report or related work;

64

●establishing
                                            procedures for the receipt, retention and treatment of complaints received by us regarding
                                            accounting, internal accounting controls or reports which raise material issues regarding
                                            our financial statements or accounting policies; and

●approving
                                            reimbursement of expenses incurred by our management team in identifying potential target
                                            businesses.

The Audit Committee is composed exclusively of
“independent directors” who are “financially literate” as defined under the Nasdaq listing standards. The Nasdaq
listing standards define “financially literate” as being able to read and understand fundamental financial statements, including
a company’s balance sheet, income statement and cash flow statement.

Compensation Committee

We have established the Compensation Committee,
which is composed exclusively of independent directors consisting of Paul Field, who is the Chairman of the Compensation Committee, Charles
Allen and Stephen Toovey. Each member of the Compensation Committee is a non-employee director, as defined under Rule 16b-3 promulgated
under the Exchange Act, and an outside director, as defined pursuant to Section 162(m) of the Code. Our Board adopted a Compensation
Committee Charter on March 16, 2023, which was deemed